A COVID-19 vaccine candidate, co-developed by the American multinational company Johnson and Johnson, raises neutralising antibodies that robustly protect hamsters against severe infection with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback